These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Sjögren's Syndrome: Early diagnosis and effective treatment].
    Author: Witte T.
    Journal: Dtsch Med Wochenschr; 2018 Dec; 143(24):1778-1782. PubMed ID: 30508859.
    Abstract:
    Primary Sjögren's syndrome (pSS) is an autoimmune disease affecting the salivary and lachrymal glands. The patients complain of symptoms of dry eyes and dry mouth, but up to 50 % may additionally develop extraglandular manifestations such as arthritis, vasculitis, polyneuropathy, pulmonary fibrosis or interstitial nephritis. Most therapeutic studies on the glandular manifestations of pSS failed to meet their primary endpoints, possibly since many of the patients had already advanced and irreversible disease.In recent years several important advances have been made. The role of B and T lymphocytes in the pathogenesis of pSS has been identified. The disease activity scores ESSDAI and ESSPRI were developed and can now be used as endpoints in therapeutical studies. Since then, numerous promising new drugs, mostly affecting B and T lymphocytes, have been studied in clinical trials. New classification criteria have been proposed, which will be an important tool in making a diagnosis in an early disease stage, in which the glandular function may still be normal. It is very likely therefore, that we will soon have efficient therapies, which will be able to stop the disease progression in an early stage of pSS. Fortschritte im Verständnis der Pathophysiologie des primären Sjögren-Syndroms und die Erarbeitung von Aktivitätscores führten zur Entwicklung und Erprobung neuer Therapieansätze. Aktuell laufen mindestens 17 kontrollierte Studien beim primären Sjögren-Syndrom. FRüHERKENNUNG:  Neue Klassifikationskriterien wurden etabliert, mit denen die Erkrankung schon im Frühstadium und bei extraglandulären Manifestationen erfasst werden kann. Die Sonografie der Speicheldrüsen bietet weiteres Potenzial für die Verbesserung der Sensitivität der Diagnostik.
    [Abstract] [Full Text] [Related] [New Search]